Latest News

The major AI investment options are all great buys now.

Two Southwest 737 MAX incidents renew scrutiny of Boeing stock even as production stabilizes, with rising jet fuel costs adding further pressure on Boeing and Southwest Airlines shares.

Meta Platforms is reportedly going to sell its excess cloud computing capacity, a move that could open a multibillion-dollar business opportunity for the company.

Rocket Lab has several company-specific catalysts and risks that investors should understand before making the call.

Several options are on the table, but few are good ones.

Sometimes a stock's reaction tells you more than the news itself, and this one deserves a closer look.

DigitalOcean shares jumped over 10% after strong preliminary Q2 results and a surge in AI-driven contracted revenue, though heavy insider selling and a 57x P/E ratio warrant caution.

This new IPO stock saw a key insider recently trim their stake by almost 40%.

Think things through before making your decision.

Non-lethal weapons company Byrna (NASDAQ:BYRN) missed Wall Street’s revenue expectations in Q2 CY2026, with sales falling 42.5% year on year to $16.39 millio...

The near-term outlook for Micron appears promising.

SpaceX is building an ecosystem that no other company can copy.

The famed portfolio manager was busy buying stocks on pullbacks recently.

The global Complementary And Alternative Medicine (CAM) Market was valued at USD 222.6 billion in 2025 and is projected to grow from USD 277.5 billion in 2

Are you searching for the most trusted beauty parlour in Anand where every visit leaves you feeling refreshed, confident, and absolutely radiant? Whether y

Tamari Shahar retains ~3.9 million shares worth $146.7 million, with additional derivative securities extending through 2029.

Rivian's $1.2 billion offering of 75 million shares sparked a share price drop, but the capital could aid manufacturing scale-up and its R2 launch despite dilution concerns.

A move can bring a mix of excitement and responsibility. Whether you are starting fresh in a new home, relocating for work, moving closer to family, or pre

CEO Uzzell discusses $402.1M sales growth and debt reduction strategy.

VHT offers broad diversification across 429 healthcare holdings, while PPH concentrates on 26 drugmakers for higher growth potential.

State Street's fund covers emerging markets and small-caps with a lower expense ratio, while iShares focuses on developed markets only.

The market is up 10% this year, but that masks what's been happening lately.

Despite the excitement around Tesla's robotaxis and Optimus robots, investors will be disappointed in the short-term, this analyst argues.

The global Clinical Trial Supplies Market size was valued at USD 5.7 billion in 2025 and is projected to grow from USD 6.1 billion in 2026 to USD 10.7 bill

GOP megadonor Ken Griffin reportedly backed Marco Rubio over JD Vance in a potential 2028 Republican presidential primary.